|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:alternativeName
|
gptkb:Measles,_Mumps,_and_Rubella_vaccine
|
|
gptkbp:approvedBy
|
1971
|
|
gptkbp:ATCCode
|
gptkb:J07BD52
|
|
gptkbp:boosterRecommended
|
no
|
|
gptkbp:contains
|
live attenuated measles virus
live attenuated mumps virus
live attenuated rubella virus
|
|
gptkbp:contraindication
|
pregnancy
severe allergic reaction to vaccine component
severe immunodeficiency
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Maurice_Hilleman
|
|
gptkbp:effect
|
over 95% after two doses
|
|
gptkbp:firstDoseAge
|
12-15 months
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MMR Vaccine
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:prevention
|
gptkb:measles
gptkb:mumps
gptkb:rubella
|
|
gptkbp:recommendation
|
children
|
|
gptkbp:recommendedDose
|
two doses
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:secondDoseAge
|
4-6 years
|
|
gptkbp:sideEffect
|
fever
swelling at injection site
mild rash
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:usedIn
|
routine childhood immunization schedule
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Immunization_Clinic
|
|
gptkbp:bfsLayer
|
5
|